Source link : https://www.newshealth.biz/health-news/the-case-for-biomarker-testing-in-gastroesophageal-cancer/
Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, biomarker testing needs to improve, explained Yelena Janjigian, MD, chief of gastrointestinal oncology at the Memorial Sloan Kettering Cancer Center in New York City. “The biomarker revolution […]
Author : News Health
Publish date : 2024-01-22 07:30:12
Copyright for syndicated content belongs to the linked Source.